Emerging respiratory infections: The infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella

Seminars in Diagnostic Pathology

Volumn 36, Issue 3, 2019, Pages 152-159

  Bradley, Benjamin T ^a   Bryan, Andrew ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Influenza; Legionella; MERS; Pathology; SARS

Indexed keywords

2009 H1N1 INFLUENZA; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; INFLUENZA VIRUS; LABORATORY DIAGNOSIS; LEGIONELLA; LEGIONNAIRE DISEASE; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORBIDITY; MORTALITY; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SARS CORONAVIRUS; SEASONAL VARIATION; SEVERE ACUTE RESPIRATORY SYNDROME; CORONAVIRUS INFECTION; INFLUENZA; PATHOLOGY;

CORONAVIRUS INFECTIONS; HUMANS; INFLUENZA, HUMAN; LEGIONELLOSIS; RESPIRATORY TRACT INFECTIONS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 85064905025     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2019.04.006     Document Type: Review

References (86)

1. Guan, Y., Zheng, B.J., He, Y.Q., et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China. Science 302:5643 (2003), 276–278, 10.1126/science.1087139.
2. CDC. Disease of the Week week - SARS. Centers for Disease Control and Prevention. http://www.cdc.gov.offcampus.lib.washington.edu/dotw/sars/index.html. Published March 3, 2016. Accessed 15 January 2019.
3. Hu, B., Zeng, L.-P., Yang, X.-L., et al. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. Drosten C., ed. PLoS Pathog, 13(11), 2017, e1006698, 10.1371/journal.ppat.1006698.
4. Olsen, S.J., Chang, H.-L., Cheung, T.Y.-Y., et al. Transmission of the severe acute respiratory syndrome on aircraft. N Engl J Med 349:25 (2003), 2416–2422, 10.1056/NEJMoa031349.
5. Leung, C., Kwan, Y., Ko, P., et al. Severe acute respiratory syndrome among children. Pediatrics 113:6 (2004), e535–e543, 10.1542/peds.113.6.e535.
6. Chan, J.C.K., Tsui, E.L.H., Wong, V.C.W., Group* THASC. Prognostication in severe acute respiratory syndrome: a retrospective time-course analysis of 1312 laboratory-confirmed patients in Hong Kong. Respirology 12:4 (2007), 531–542, 10.1111/j.1440-1843.2007.01102.x.
7. Nicholls, J.M., Poon, L.L.M., Lee, K.C., et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 361:9371 (2003), 1773–1778, 10.1016/S0140-6736(03)13413-7.
8. Gu, J., Gong, E., Zhang, B., et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med 202:3 (2005), 415–424, 10.1084/jem.20050828.
9. Ding, Y., Wang, H., Shen, H., et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol 200:3 (2003), 282–289, 10.1002/path.1440.
10. Franks, T.J., Chong, P.Y., Chui, P., et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol 34:8 (2003), 743–748, 10.1016/S0046-8177(03)00367-8.
11. To, K.F., Tong, J.H.M., Chan, P.K.S., et al. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in‐situ hybridization study of fatal cases. J Pathol 202:2 (2004), 157–163, 10.1002/path.1510.
12. Shieh, W.-J., Hsiao, C.-H., Paddock, C.D., et al. Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan. Hum Pathol 36:3 (2005), 303–309, 10.1016/j.humpath.2004.11.006.
13. Grant, P.R., Garson, J.A., Tedder, R.S., Chan, P.K.S., Tam, J.S., Sung, J.J.Y., Detection of SARS coronavirus in plasma by real-time RT-PCR. N Engl J Med 349:25 (2003), 2468–2469, 10.1056/NEJM200312183492522.
14. Chan, K.H., Poon, L.L.L.M., Cheng, V.C.C., et al. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis 10:2 (2004), 294–299, 10.3201/eid1002.030610.
15. Kuiken, T., Fouchier, R.A.M., Schutten, M., et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362:9380 (2003), 263–270, 10.1016/S0140-6736(03)13967-0.
16. Li, G., Chen, X., Xu, A., Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med 349:5 (2003), 508–509, 10.1056/NEJM200307313490520.
17. Peiris, J.S.M., Chu, C.M., Cheng, V.C.C., et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361:9371 (2003), 1767–1772.
18. Woo, P.C.Y., Lau, S.K.P., Wong, B.H.L., et al. Longitudinal Profile of Immunoglobulin G (IgG), IgM, and IgA Antibodies against the Severe Acute Respiratory Syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin Diagn Lab Immunol 11:4 (2004), 665–668, 10.1128/CDLI.11.4.665-668.2004.
19. Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D.M.E., Fouchier, R.A.M., Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:19 (2012), 1814–1820, 10.1056/NEJMoa1211721.
20. WHO | Middle East respiratory syndrome coronavirus (MERS-CoV), WHO. 2019 http://www.who.int/emergencies/mers-cov/en/. Accessed 16 January 2019.
21. Azhar, E.I., El-Kafrawy, S.A., Farraj, S.A., et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 370:26 (2014), 2499–2505, 10.1056/NEJMoa1401505.
22. Memish, Z.A., Mishra, N., Olival, K.J., et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 19:11 (2013), 1819–1823, 10.3201/eid1911.131172.
23. Arabi, Y.M., Balkhy, H.H., Hayden, F.G., et al. Middle East respiratory syndrome. N Engl J Med 376:6 (2017), 584–594, 10.1056/NEJMsr1408795.
24. Arwady, M.A., Alraddadi, B., Basler, C., et al. Middle East respiratory syndrome coronavirus transmission in extended family, Saudi Arabia, 2014. Emerg Infect Dis 22:8 (2016), 1395–1402, 10.3201/eid2208.152015.
25. Oboho, I.K., Tomczyk, S.M., Al-Asmari, A.M., et al. 2014 MERS-CoV outbreak in Jeddah–a link to health care facilities. N Engl J Med 372:9 (2015), 846–854, 10.1056/NEJMoa1408636.
26. Müller, M.A., Meyer, B., Corman, V.M., et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis 15:5 (2015), 559–564, 10.1016/S1473-3099(15)70090-3.
27. Walker, D.H., Value of autopsy emphasized in the case report of a single patient with Middle East respiratory syndrome. Am J Pathol 186:3 (2016), 507–510, 10.1016/j.ajpath.2015.11.001.
28. Ng, D.L., Hosani, F., Keating, M.K., et al. Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014. Am J Pathol 186:3 (2016), 652–658, 10.1016/j.ajpath.2015.10.024.
29. Ng, D.L., Al Hosani, F., Keating, M.K., et al. Clinicopathologic, Immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014. Am J Pathol 186:3 (2016), 652–658, 10.1016/j.ajpath.2015.10.024.
30. Alsaad, K.O., Hajeer, A.H., Al Balwi, M., et al. Histopathology of Middle East respiratory syndrome coronovirus (MERS‐CoV) infection – clinicopathological and ultrastructural study. Histopathology 72:3 (2018), 516–524, 10.1111/his.13379.
31. Cha, R., Yang, S.H., Moon, K.C., et al. A case report of a Middle East respiratory syndrome survivor with kidney biopsy results. J Korean Med Sci 31:4 (2016), 635–640, 10.3346/jkms.2016.31.4.635.
32. Zhou, J., Li, C., Zhao, G., et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci Adv, 3(11), 2017, eaao4966, 10.1126/sciadv.aao4966.
33. Chan, R.W.Y., Hemida, M.G., Kayali, G., et al. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir Med 2:10 (2014), 813–822, 10.1016/S2213-2600(14)70158-4.
34. Yeung, M.-L., Yao, Y., Jia, L., et al. MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat Microbiol, 1(3), 2016, 16004, 10.1038/nmicrobiol.2016.4.
35. Corman, V.M., Albarrak, A.M., Omrani, A.S., et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin Infect Dis Off Publ Infect Dis Soc Am 62:4 (2016), 477–483, 10.1093/cid/civ951.
36. Li, K., Wohlford-Lenane, C.L., Channappanavar, R., et al. Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proc Natl Acad Sci 114:15 (2017), E3119–E3128, 10.1073/PNAS.1619109114.
37. de Wit, E., Rasmussen, A.L., Falzarano, D., et al. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci 110:41 (2013), 16598–16603, 10.1073/pnas.1310744110.
38. Baseler, L.J., Falzarano, D., Scott, D.P., et al. An acute immune response to Middle East respiratory syndrome coronavirus replication contributes to viral pathogenicity. Am J Pathol 186:3 (2016), 630–638, 10.1016/j.ajpath.2015.10.025.
39. Yao, Y., Bao, L., Deng, W., et al. An animal model of MERS Produced by infection of rhesus macaques With MERS coronavirus. J Infect Dis 209:2 (2014), 236–242, 10.1093/infdis/jit590.
40. Kim, S.Y., Park, S.J., Cho, S.Y., et al. Viral RNA in blood as indicator of severe outcome in Middle East respiratory syndrome coronavirus infection. Emerg Infect Dis 22:10 (2016), 1813–1816, 10.3201/eid2210.160218.
41. Corman, V.M., Ölschläger, S., Wendtner, C.-M., Drexler, J.F., Hess, M., Drosten, C., Performance and clinical validation of the RealStar® MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA. J Clin Virol 60:2 (2014), 168–171, 10.1016/j.jcv.2014.03.012.
42. Lu, X., Whitaker, B., Sakthivel, S.K.K., et al. Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus. J Clin Microbiol 52:1 (2014), 67–75, 10.1128/JCM.02533-13.
43. Al-Abdallat, M.M., Payne, D.C., Alqasrawi, S., et al. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis 59:9 (2014), 1225–1233, 10.1093/cid/ciu359.
44. Choe, P.G., Perera, R.A.P.M., Park, W.B., et al. MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015. Emerg Infect Dis 23:7 (2017), 1079–1084, 10.3201/eid2307.170310.
45. Writing committee of the WHO consultation on clinical aspects of pandemic (H1N1) 2009 influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 362:18 (2010), 1708–1719, 10.1056/NEJMra1000449.
46. Garten, R.J., Davis, C.T., Russell, C.A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:5937 (2009), 197–201, 10.1126/science.1176225.
47. Past Pandemics | Pandemic Influenza (Flu) | CDC. http://www.cdc.gov/flu/pandemic-resources/basics/past-pandemics.html. Published August 10, 2018. Accessed 18 January 2019.
48. Lee, N., Chan, P.K.S., Lui, G.C.Y., et al. Complications and outcomes of pandemic 2009 influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza. J Infect Dis 203:12 (2011), 1739–1747, 10.1093/infdis/jir187.
49. Cheng, V.C.C., To, K.K.W., Tse, H., Hung, I.F.N., Yuen, K.-Y., Two years after pandemic influenza A/2009/H1N1: what have we learned?. Clin Microbiol Rev 25:2 (2012), 223–263, 10.1128/CMR.05012-11.
50. Kumar, A., Zarychanski, R., Pinto, R., et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA, 302(17), 2009, 1872, 10.1001/jama.2009.1496.
51. Shieh, W.-J., Blau, D.M., Denison, A.M., et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 177:1 (2010), 166–175, 10.2353/AJPATH.2010.100115.
52. Shelke, V.N., Kolhapure, R.M., Kadam, D., et al. Pathologic study of pandemic influenza A (H1N1) 2009 cases from India. Pathol Int 62:1 (2012), 36–42, 10.1111/j.1440-1827.2011.02751.x.
53. Nakajima, N., Sato, Y., Katano, H., et al. Histopathological and immunohistochemical findings of 20 autopsy cases with 2009 H1N1 virus infection. Mod Pathol 25:1 (2012), 1–13, 10.1038/modpathol.2011.125.
54. Brooks, E.G., Bryce, C.H., Avery, C., Smelser, C., Thompson, D., Nolte, K.B., 2009 H1N1 fatalities: the new mexico experience. J Forensic Sci 57:6 (2012), 1512–1518, 10.1111/j.1556-4029.2012.02163.x.
55. Mauad, T., Hajjar, L.A., Callegari, G.D., et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 181:1 (2010), 72–79, 10.1164/rccm.200909-1420OC.
56. Soto-Abraham, M.V., Soriano-Rosas, J., Díaz-Quiñónez, A., et al. Pathological changes associated with the 2009 H1N1 virus. N Engl J Med 361:20 (2009), 2001–2003, 10.1056/NEJMc0907171.
57. Gill, J.R., Sheng, Z.-M., Ely, S.F., et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 134 (2010), 235–243.
58. Sellers, S.A., Hagan, R.S., Hayden, F.G., Fischer, W.A., The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection. Influenza Other Respir Viruses 11:5 (2017), 372–393, 10.1111/irv.12470.
59. Guarner, J., Paddock, C.D., Shieh, W., et al. Histopathologic and Immunohistochemical features of fatal influenza virus infection in children during the 2003–2004 season. Clin Infect Dis 43:2 (2006), 132–140, 10.1086/505122.
60. Munster, V.J., de Wit, E., van den Brand, J.M.A., et al. Pathogenesis and transmission of swine-origin 2009 A (H1N1) influenza virus in ferrets. Science 325:5939 (2009), 481–483, 10.1126/science.1177127.
61. Itoh, Y., Shinya, K., Kiso, M., et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460:7258 (2009), 1021–1025, 10.1038/nature08260.
62. Safronetz, D., Rockx, B., Feldmann, F., et al. Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J Virol 85:3 (2011), 1214–1223, 10.1128/JVI.01848-10.
63. Taubenberger, J.K., Morens, D.M., The pathology of influenza virus infections. Annu Rev Pathol Mech Dis 3:1 (2008), 499–522, 10.1146/annurev.pathmechdis.3.121806.154316.
64. Merckx, J., Wali, R., Schiller, I., et al. Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction: a systematic review and meta-analysis. Ann Intern Med 167:6 (2017), 394–409, 10.7326/M17-0848.
65. Chartrand, C., Leeflang, M.M.G., Minion, J., Brewer, T., Pai, M., Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med 156:7 (2012), 500–511, 10.7326/0003-4819-156-7-201204030-00403.
66. Kumar, S., Henrickson, K.J., Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic. Clin Microbiol Rev 25:2 (2012), 344–361, 10.1128/CMR.05016-11.
67. Lee N. Pathogenesis of pandemic H1N1 in humans. In: Presented at the XII in - ternational symposium on respiratory viral infections, Taipei, Taiwan.
68. To, K.K.W., Hung, I.F.N., Li, I.W.S., et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 50:6 (2010), 850–859, 10.1086/650581.
69. Pierre, D.M., Baron, J., Yu, V.L., Stout, J.E., Diagnostic testing for Legionnaires’ disease. Ann Clin Microbiol Antimicrob, 2017, 16, 10.1186/s12941-017-0229-6.
70. Muder, R.R., Victor, L.Y., Infection due to Legionella species other than L. pneumophila. Clin Infect Dis 35:8 (2002), 990–998, 10.1086/342884.
71. Sivagnanam, S., Podczervinski, S., Butler-Wu, S.M., et al. Legionnaires’ disease in transplant recipients: a 15-year retrospective study in a tertiary referral center. Transpl Infect Dis Off J Transplant Soc, 19(5), 2017, 10.1111/tid.12745.
72. Cunha, B.A., Burillo, A., Bouza, E., Legionnaires’ disease. The Lancet 387:10016 (2016), 376–385, 10.1016/S0140-6736(15)60078-2.
73. Probable Person-to-Person Transmission of Legionnaires’ Disease | NEJM. https://www-nejm-org.offcampus.lib.washington.edu/doi/full/10.1056/NEJMc1505356?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed. Accessed 17 January 2019.
74. Legionnaires Disease History and Patterns | Legionella | CDC. http://www.cdc.gov/legionella/about/history.html. Published November 26, 2018. Accessed 17 January 2019.
75. Sivagnanam, S., Podczervinski, S., Butler‐Wu, S.M., et al. Legionnaires’ disease in transplant recipients: a 15-year retrospective study in a tertiary referral center. Transpl Infect Dis, 19(5), 2017, e12745, 10.1111/tid.12745.
76. Bargellini, A., Marchesi, I., Marchegiano, P., et al. A culture-proven case of community-acquired legionella pneumonia apparently classified as nosocomial: diagnostic and public health implications. Case Rep Med, 2013, 2013, 303712, 10.1155/2013/303712.
77. Cunha, B.A., Cunha, C.B., Legionnaire's disease: a clinical diagnostic approach. Infect Dis Clin North Am 31:1 (2017), 81–93, 10.1016/j.idc.2016.10.007.
78. Rudin, J.E., Wing, E.J., A comparative study of Legionella micdadei and other nosocomial acquired pneumonia. Chest 86:5 (1984), 675–680.
79. Joshi, A.D., Swanson, M.S., Comparative analysis of Legionella pneumophila and Legionella micdadei virulence traits. Infect Immun 67:8 (1999), 4134–4142.
80. Blackmon, J.A., Chandler, F.W., Cherry, W.B., et al. Legionellosis. Am J Pathol 103:3 (1981), 429–465.
81. Winn, W.C., Myerowitz, R.L., The pathology of the legionella pneumonias: a review of 74 cases and the literature. Hum Pathol 12:5 (1981), 401–422, 10.1016/S0046-8177(81)80021-4.
82. Waldron, P.R., Martin, B.A., Ho, D.Y., Mistaken identity: Legionella micdadei appearing as acid fast bacilli on lung biopsy of a hematopoietic stem cell transplant patient. Transpl Infect Dis Off J Transplant Soc 17:1 (2015), 89–93, 10.1111/tid.12334.
83. Kohler, R.B., Winn, W.C., Wheat, L.J., Onset and duration of urinary antigen excretion in Legionnaires disease. J Clin Microbiol 20:4 (1984), 605–607.
84. Salipante, S.J., SenGupta, D.J., Cummings, L.A., Land, T.A., Hoogestraat, D.R., Cookson, B.T., Application of whole-genome sequencing for bacterial strain typing in molecular epidemiology. J Clin Microbiol 53:4 (2015), 1072–1079, 10.1128/JCM.03385-14.
85. Avni, T., Bieber, A., Green, H., Steinmetz, T., Leibovici, L., Paul, M., Diagnostic accuracy of PCR alone and compared to urinary antigen testing for detection of Legionella spp.: a systematic review. J Clin Microbiol 54:2 (2016), 401–411, 10.1128/JCM.02675-15.
86. IATA. Traveler Numbers Reach New Heights. https://www.iata.org/pressroom/pr/pages/2018-09-06-01.aspx. Accessed 18 January 2019.